Modified bacteria could fight this brain-damaging genetic disease
Cambridge-based biotech Synlogic’s bacteria-based treatment for phenylketonuria (PKU) has shown positive results in a small phase 2 trial, the company announced in October – proof of concept for the idea of using modified strains of beneficial bacteria to treat disease. “Diseases like PKU are good fruit at hand to answer the first question, which is …
Modified bacteria could fight this brain-damaging genetic disease Read More »